相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study
Yingzhen Du et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
COVID-19 and its implications for thrombosis and anticoagulation
Jean M. Connors et al.
BLOOD (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
Pei-Fang Wei
CHINESE MEDICAL JOURNAL (2020)
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019
Thomas K. Maatman et al.
CRITICAL CARE MEDICINE (2020)
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Gian Battista Danzi et al.
EUROPEAN HEART JOURNAL (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Marco Cattaneo et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection
Franklin L. Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2020)
Incidence of venous thromboembolism in hospitalized patients with COVID-19
Saskia Middeldorp et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
Marco Ranucci et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Ricardo J. Jose et al.
LANCET RESPIRATORY MEDICINE (2020)
Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
Sharon E. Fox et al.
LANCET RESPIRATORY MEDICINE (2020)
Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
Elizabeth A. Middleton et al.
BLOOD (2020)
Platelet gene expression and function in patients with COVID-19
Bhanu Kanth Manne et al.
BLOOD (2020)
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study
Danying Liao et al.
LANCET HAEMATOLOGY (2020)
Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19
Yang Liu et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
Eugenio D. Hottz et al.
BLOOD (2020)
Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry
Rahul Chaudhary et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography
D. C. Rotzinger et al.
THROMBOSIS RESEARCH (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Update to coagulopathy in COVID-19: Manifestations and management
Simon R. Mucha et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2020)
A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies
Deborah M. Siegal et al.
BLOOD ADVANCES (2020)
Acute pulmonary embolism and COVID-19 pneumonia: a random association?
Gian Battista Danzi et al.
EUROPEAN HEART JOURNAL (2020)
Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation
Toshiaki Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation
Toshiaki Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases
Toshiaki Iba et al.
THROMBOSIS RESEARCH (2019)
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
Shaun P. Jackson et al.
BLOOD (2019)
Derangement of the endothelial glycocalyx in sepsis
T. Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH
T. Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis
T. Iba et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH
K. Suzuki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
How I treat disseminated intravascular coagulation
Marcel Levi et al.
BLOOD (2018)
Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy
Melissa E. Schechter et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Breaking the chain of zoonoses through biosecurity in livestock
Daniel S. Layton et al.
VACCINE (2017)
Immunohaemostasis: a new view on haemostasis during sepsis
Xavier Delabranche et al.
ANNALS OF INTENSIVE CARE (2017)
EXTRACELLULAR HISTONES INCREASE TISSUE FACTOR ACTIVITY AND ENHANCE THROMBIN GENERATION BY HUMAN BLOOD MONOCYTES
Travis J. Gould et al.
SHOCK (2016)
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections
F. J. Sherida H. Woei-A-Jin et al.
THROMBOSIS RESEARCH (2014)
Thrombosis as an intravascular effector of innate immunity
Bernd Engelmann et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Harmful molecular mechanisms in sepsis
Daniel Rittirsch et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Inflammation and thrombosis
CT Esmon
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
CD40L stabilizes arterial thrombi by a beta(3) integrin-dependent mechanism
P Andre et al.
NATURE MEDICINE (2002)
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation - On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)
FB Taylor et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study
E Abraham et al.
CRITICAL CARE MEDICINE (2001)
Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock
R Matyal et al.
INTENSIVE CARE MEDICINE (2001)
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
E de Jonge et al.
BLOOD (2000)